CORZ
Core Scientific, Inc
Core Scientific, Inc historical holders
total: 3
Third Point Core Scientific, Inc transactions over time
- Total transactions:
- 3
- New positions:
- 2
- Sold out:
- 1
- Held since:
- 2026 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
Daniel Loeb has been an institutional investor in Core Scientific, Inc (CORZ) since 2025 Q3. According to 2026 Q2 report, Daniel Loeb holds 54,000 shares with a market value of roughly $1.38M representing 0.03% of their equity portfolio. The fund/company first acquired CORZ in 2025 Q3, initially purchasing about 3.00M shares. Daniel Loeb later completely sold out the position and reinvested in CORZ again in 2026 Q2. Since the initial investment, Third Point has made 2 more transactions in this position.
Does Daniel Loeb still hold CORZ?
Yes, Daniel Loeb continues to hold Core Scientific, Inc (CORZ). According to their 2026 Q2 report, they maintain a position of 54,000 shares valued at approximately $1.38M, representing 0.03% of their equity portfolio.
When did Daniel Loeb first invest in CORZ?
Daniel Loeb first invested in Core Scientific, Inc (CORZ) in 2025 Q3 at the reported quarter-end price of $17.94 per share, acquiring 3,000,000 shares in their initial purchase.
What is Daniel Loeb's average cost basis for CORZ?
Based on historical transaction data, Daniel Loeb's estimated cost basis for Core Scientific, Inc (CORZ) is approximately $25.59 per share. This represents their average reported price* across all buy transactions.
Has Daniel Loeb reinvested in CORZ after selling?
Yes, Daniel Loeb has shown renewed interest in Core Scientific, Inc (CORZ). After completely selling their position, they reinitiated an investment in 2026 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $25.59
CORZ transactions history by Third Point
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.03%
|
54,000
|
$25.59
|
$1,381,860
|
new
|
+0.03%
|
|
2025 Q4
|
0.00%
|
0
|
$17.94
|
|
-100% (-3,000,000)
|
-0.64%
|
|
2025 Q3
|
0.64%
|
3,000,000
|
$17.94
|
$53,820,000
|
new
|
+0.64%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.